Menopause Hot Flashes: New Study Shows Dramatic Symptom Relief

In the OASIS-3 trial, a 52-week study involving over 600 postmenopausal women, participants took either elinzanetant or a placebo.

Key results:

• 73% reduction in hot flashes and night sweats by week 12 (vs. 47% with placebo)

• Benefits sustained through the full year of the study

• Side effects were mild: primarily headaches, fatigue, or drowsiness

For women who've struggled with disrupted sleep for months or years, these numbers represent meaningful relief.

-Non-hormonal options are limited. Hormone therapy helps some women, but it's not safe or appropriate for everyone, particularly those with certain cancer histories or cardiovascular risks.

-Quality of life extends beyond symptoms. Better sleep improves mood, energy, focus, and daily functioning. Addressing night sweats addresses much more than nighttime discomfort.

• Individual responses vary → Not everyone will experience the same level of relief

• Not yet FDA-approved in the US → Availability depends on regulatory status in your location

• Consult your healthcare provider → Any new treatment should be discussed with your doctor, especially if you have existing health conditions

If menopause has turned your nights into a battleground, elinzanetant represents a potential new option, particularly for those who can't or prefer not to use hormone therapy.

It's not a miracle cure. But for many women, it could mean cooler nights, better sleep, and brighter mornings.